KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Esperion Therapeutics (ESPR) Shares Issued (2018 - 2025)

Historic Shares Issued for Esperion Therapeutics (ESPR) over the last 8 years, with Q3 2025 value amounting to $141000.0.

  • Esperion Therapeutics' Shares Issued changed N/A to $141000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $141000.0, marking a year-over-year decrease of 9990.15%. This contributed to the annual value of $90.7 million for FY2024, which is 7294.58% up from last year.
  • Per Esperion Therapeutics' latest filing, its Shares Issued stood at $141000.0 for Q3 2025.
  • In the past 5 years, Esperion Therapeutics' Shares Issued ranged from a high of $204.6 million in Q4 2021 and a low of $141000.0 during Q3 2025
  • For the 5-year period, Esperion Therapeutics' Shares Issued averaged around $44.3 million, with its median value being $21.1 million (2022).
  • Within the past 5 years, the most significant YoY rise in Esperion Therapeutics' Shares Issued was 8550125.52% (2021), while the steepest drop was 9550.56% (2021).
  • Quarter analysis of 5 years shows Esperion Therapeutics' Shares Issued stood at $204.6 million in 2021, then tumbled by 89.25% to $22.0 million in 2022, then skyrocketed by 138.44% to $52.4 million in 2023, then soared by 72.95% to $90.7 million in 2024, then crashed by 99.84% to $141000.0 in 2025.
  • Its Shares Issued was $141000.0 in Q3 2025, compared to $90.7 million in Q1 2024 and $52.4 million in Q4 2023.